Literature DB >> 18804186

Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment.

Ozalp Ekinci1, Jeffrey B Titus, Ayse Arman Rodopman, Meral Berkem, Edwin Trevathan.   

Abstract

Among the psychiatric comorbid conditions in children and adolescents with epilepsy, depression and anxiety disorders require further attention because they carry the risk of reduced quality of life and life-threatening complications (e.g., suicide). Research in recent years has shed light on both the prevalence of emotional problems in youth with epilepsy and the safety and efficacy of treatment options. A number of challenges exist in treating patients with epilepsy. This is particularly true when seizures are difficult to control and medication regimens are more complex. Some pharmaceutical options may provide assistance with both seizures and emotional distress, but care is needed when considering such treatment approaches. In addition, integration of mental health professionals into the care of patients is necessary when cases are complicated and risk factors are high. Thorough methods to accurately diagnose emotional conditions and regular monitoring of symptoms can help prevent serious problems that can negatively affect the success of children and adolescents in everyday life. Collaboration between disciplines offers the best hope for early identification and treatment of these conditions.

Entities:  

Mesh:

Year:  2008        PMID: 18804186     DOI: 10.1016/j.yebeh.2008.08.015

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  32 in total

1.  Anxiety in medically ill children/adolescents.

Authors:  Maryland Pao; Abigail Bosk
Journal:  Depress Anxiety       Date:  2010-08-18       Impact factor: 6.505

Review 2.  Depression in epilepsy: a critical review from a clinical perspective.

Authors:  Christian Hoppe; Christian E Elger
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

3.  Depression and anxiety in children with epilepsy and other chronic health conditions: National estimates of prevalence and risk factors.

Authors:  Brian LaGrant; Belinda Oyinkan Marquis; Anne T Berg; Zachary M Grinspan
Journal:  Epilepsy Behav       Date:  2019-12-20       Impact factor: 2.937

4.  Rearing by foster Wistar mother with high level of maternal care counteracts the development of genetic absence epilepsy and comorbid depression in WAG/Rij rats.

Authors:  K Yu Sarkisova; A V Gabova; M A Kulikov; E A Fedosova; A B Shatskova; A A Morosov
Journal:  Dokl Biol Sci       Date:  2017-05-16

5.  Health care needs of children with Tourette syndrome.

Authors:  Rebecca H Bitsko; Melissa Danielson; Michael King; Susanna N Visser; Lawrence Scahill; Ruth Perou
Journal:  J Child Neurol       Date:  2012-11-08       Impact factor: 1.987

Review 6.  Depressive syndromes in neurological disorders.

Authors:  Julian Hellmann-Regen; Dominique Piber; Kim Hinkelmann; Stefan M Gold; Christoph Heesen; Carsten Spitzer; Matthias Endres; Christian Otte
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11       Impact factor: 5.270

7.  Understanding the social networks of parents of children with sickle cell disease.

Authors:  Lisa M Vaughn; Daniel McLinden; Farrah Jacquez; Lori Crosby; Shalonda Slater; Monica Mitchell
Journal:  J Health Care Poor Underserved       Date:  2011-08

Review 8.  [Depression and neurological diseases].

Authors:  D Piber; K Hinkelmann; S M Gold; C Heesen; C Spitzer; M Endres; C Otte
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

9.  Alexithymia and posttraumatic stress disorder following epileptic seizure.

Authors:  Man Cheung Chung; Rachel D Allen
Journal:  Psychiatr Q       Date:  2013-09

Review 10.  Psychological treatments for people with epilepsy.

Authors:  Rosa Michaelis; Venus Tang; Janelle L Wagner; Avani C Modi; William Curt LaFrance; Laura H Goldstein; Tobias Lundgren; Markus Reuber
Journal:  Cochrane Database Syst Rev       Date:  2017-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.